FDA faces deadline for cannabis guidance this week (Newsletter: February 9, 2026)

Bondi could face marijuana questions; PA legalization push; Government-run dispensary opens; Poll: Cannabis consumers back Trump’s rescheduling move

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Email address:

Your support makes Marijuana Moment possible…

Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. 

If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Food and Drug Administration is facing a Tuesday deadline in hemp recriminalization legislation signed by President Donald Trump to publish lists of cannabinoids in the plant and issue guidance on the term ‘container’” with respect to hemp product THC serving sizes. Marijuana reform advocates are hoping that a scheduled appearance by Attorney General Pam Bondi before the House Judiciary Committee on Wednesday will be an opportunity to get an update on where the cannabis rescheduling process stands. Pennsylvania House Democrats are calling on the Republican-controlled Senate to follow their lead in passing a marijuana legalization bill as Gov. Josh Shapiro (D) called for in his budget request. The Virginia Senate Education and Health Committee approved a bill to allow patients to access medical cannabis in hospitals—but only if the federal government moves forward with a pending plan to reschedule marijuana. A government-run marijuana dispensary in Anoka, Minnesota has officially opened its doors for sales—with the mayor saying cannabis revenue will help to ensure “safe, vibrant and well maintained communities, while keeping taxes as low as practicable” for residents. A new poll from NuggMD shows that marijuana consumers living in legal states overwhelmingly support President Donald Trump’s federal rescheduling executive order and care about its impacts on easing research and providing tax benefits to cannabis businesses. The Florida House Criminal Justice Subcommittee approved a bill to ban medical cannabis patients from possessing open containers of marijuana in vehicles, with the possibility of losing their registrations as a punishment. Arkansas medical cannabis advocates are concerned that a stateSupreme Court ruling allowing lawmakers to amend voter-approved ballot initiatives opens the door to roll back patient access. Some Ohio cannabis industry operators are opposing an effort to put a referendum on the ballot to block marijuana and hemp restrictions from taking effect—saying they want to close “loopholes” on intoxicating products while accepting the recriminalization of some consumer activity. Former St. Louis, Missouri police sergeant Gary Wiegert authored an op-ed explaining why “many police chiefs, sheriffs and prosecutors across the country support President Donald Trump’s decision to change how cannabis is classified.” / FEDERAL A Food and Drug Administration plan to fast-track review of a psychedelic treatment for severe depression was reportedly blocked by Trump administration officials. The Drug Enforcement Administration is seeking to extend its policy on pre-employment drug policy notification and acknowledgement. Sen. Ashley Moody (R-FL) touted the cancellation of funds to support research on cannabis use among sexual minority and gender-diverse individuals during a Senate Health, Education, Labor, and Pensions Committee hearing. Sen. Susan Collins (R-ME) cheered the passage of legislation containing provisions to address Chinese-linked illicit marijuana growing operations. / STATES Ohio’s attorney general filed a lawsuit accusing multistate cannabis businesses of engaging in anti-competitive conduct to reduce product choice and keep prices artificially high. New Jersey’s Assembly speaker appointed a new member to the Cannabis Regulatory Commission. Kansas lawmakers filed several marijuana reform bills. A West Virginia senator filed a bill to reschedule marijuana under state law. California regulators announced a recall of marijuana products due to inaccurate ingredient labeling. Colorado regulators issued a health and safety bulletin about marijuana products with yeast, mold and aspergillus above acceptable limits. Texas regulators are moving to renew emergency hemp product rules. Nevada marijuana sales generated nearly $96 million for the State Education Fund in FIscal Year 2025. The North Carolina Advisory Council on Cannabis will meet on Tuesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —

/ SCIENCE & HEALTH A review concluded that “preclinical evidence suggests that CBD has a bone-protective role through multifaceted pathways that enhance osteoblast function and suppress osteoclast activity.” A study’s results “confirm the usefulness of [artificial intelligence Support Vector Machine]-based grayscale feature modeling for automating cannabis seed classification and improving precision agriculture through efficient, scalable, and data-driven solutions.” / ADVOCACY, OPINION & ANALYSIS The Boston Globe editorial board is calling on Massachusetts localities to update “onerous” marijuana business zoning rules. / BUSINESS The Cannabist Company Holdings Inc. closed the sale of its Virginia assets. Canopy Growth Corporation reported quarterly net revenue of C$74.5 million and a net loss of C$62.6 million. Willie’s Remedy+ announced a $15 million Series A funding round.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Email address: